1 active not recruiting, 1 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
Follow Enhanced S-Cone Syndrome: new trials by email Literature Review of Enhanced S-Cone Syndrome trials Research Report on Enhanced S-Cone Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis OCU400 Low Dose, OCU400 Med Dose, OCU400 High Dose - Retinitis Pigmentosa, Leber Congenital Amaurosis | Phase 1 / Phase 2 | Active not recruiting | Ocugen | 22 | 2022-01-24 | 2026-07-31 |
| Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS) Interferon gamma-1b - Inherited Ophthalmic Diseases, Inherited Retinal Degeneration | Phase 1 / Phase 2 | Terminated | National Eye Institute (NEI) | 4 | 2015-01-14 | 2019-08-13 |
Cone-Rod Dystrophies (1) · Leber Congenital Amaurosis (1) · Macular Edema (1) · Meckel Syndrome, Type 4 (1) · Night Blindness, Congenital Stationary, Autosomal Dominant 1 (1) · Retinitis Pigmentosa (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Retinal Degeneration (2) · Retinal Diseases (2) · Retinal Dystrophies (2) · Macular Degeneration (1)
National Eye Institute (NEI) (1) · Ocugen (1)
United States (2)
Jennifer Henrick, RN, MS (1) · Mohamed Genead, MD (1) · Wadih Zein, M.D. (1)